Nov 19, 2022 - Health

5. A roller coaster journey in search for Alzheimer's treatments

Photo illustration of a photograph of an elderly couple overlaid with an MRI scan of a brain.

Photo illustration: Aïda Amer/Axios. Photo: Smith Collection/Gado/Getty Images

More than a year after one of the most controversial drug approvals in FDA history, seniors and their loved ones may be on the cusp of having a new drug on the market that slows the progression of Alzheimer's disease.

Why it matters: Seniors desperate for relief from the debilitating disease were the real losers in the debacle over Biogen's Alzheimer's drug — which was approved through a fast-tracked process over the objection of prominent scientists.

Previous StoryNext Story